Former Alere executives are putting together a $46-per-share takeover offer for the diagnostics company, according to a Sept. 15 SEC filing. Investors didn't embrace the offer entirely, but they did send shares up about 13% to $41.33 in midafternoon trading.
Hospitals affiliated with Stanford and Duke University are initiating partnerships with Apple and its yet to be unveiled HealthKit, designed to collect data from healthcare apps and present it to doctors in a centralized location.
Medtronic launched the wireless, adhesive heart monitor that it acquired when it bought startup Corventis in June reportedly for more than $150 million. The monitor can be worn up to 30 days to detect and diagnose the cause of irregular heartbeats. But the device remains a second-line tool behind the bulky Holter monitor.
A long-anticipated acquisition of Nobel Biocare is now officially in the works as Danaher said it would acquire the dental company for about $2.2 billion. The deal is expected to make Danaher the market leader in dental equipment and consumables.
The TEDMED DC conference is packed with speakers strategically chosen to educate and entertain. Professionals from around the world share their areas of expertise with others in the field in order to gain interest and connections in their field.
Medtronic unveiled a new study over the weekend indicating its transcatheter aortic valve replacement device provides "exceptional rates of survival" for patients two years after they received its CoreValve System implant because they were considered too high risk for traditional open-heart surgery.
Abbott released one-year data of the first randomized controlled trial of 501 patients, comparing its clinical-stage Absorb Bioresorbable Vascular Scaffold to the company's counterpart, the Xience drug-eluting stent, yesterday at the Transcatheter Cardiovascular Therapeutics conference in Washington, DC.
ReWalk Robotics, which offers the first robotic exoskeleton for spinal cord injury patients to be cleared by FDA, raised $36 million in an IPO. It didn't wow investors too much--pricing below the anticipated range. Meanwhile, another medical device company stepped into the IPO queue; proton radiation therapy company Mevion Medical Systems filed to raise up to $69 million.
Medtronic yesterday announced FDA 510(k) clearance of the NC Euphora Noncompliant Balloon Dilatation Catheter to encourage stent apposition to the artery wall.
Developers and healthcare professionals are looking out for any further developments from Apple's latest release, the Apple Watch.
Kimberly-Clark's spinoff of its $1.6 billion healthcare business is scheduled to occur Nov. 1, with the launch of newly independent company Halyard Health.
AliveCor, the maker of the first FDA-approved smartphone-based device to detect atrial fibrillation, is partnering with Apollo Hospitals to provide the monitor to patients throughout India.
Researchers from the Nebraska Center for Materials and Nanoscience at the University of Nebraska have created a thin electronic skin made of nanoparticles and polymers that can be applied to the breast and used to find and image lumps.
Abbott Laboratories will invest $60 million in an intraocular lens manufacturing plant in Malaysia. The plant is expected to employ about 500 people and to be operational next year, producing 1 million sets of IOLs a year.
The Defense Advanced Research Projects Agency awarded Harvard University engineers up to $2.9 billion to develop a robotic suit to make walking easier for soldiers and potentially civilians with disabilities, the university announced today.
Deals Labs Inc. has used a traditional funding approach in conjuction with hi-tech data analysis to connect startups with investors.
Blackberry is launching an ambitious project to integrate thousands of medical devices in India in order to detect illnesses earlier.
Amid growing action from U.S. lawmakers to curb corporate inversions, top Senate Democrats revealed a plan to rein in the deals that would allow med tech companies to shift their domiciles abroad for tax-paying purposes.
Scripps Health has launched a pilot study of AirStrip One, a software system that delivers hospital patient-monitoring data to physicians' mobile devices. The 60-day pilot study, which is slated to end in early October, is intended to evaluate the potential for broader adoption.
Alan Mertz, president of the American Clinical Laboratory Association, ripped into the FDA's proposal to regulate lab-developed tests yesterday in testimony to Congress during a hearing of the 21st Century Cures initative.